Exploring the Neuroprotective Effects of Resveratrol against MDMA-induced Neurotoxicity in Rats Using Positron Emission Tomography

博士 === 國防醫學院 === 醫學科學研究所 === 104 === 3,4-methylenedioxymethamphetamine (MDMA) is a widely misused drug that has been reported to evoke acute weight loss and hypothalamic-pituitary-adrenal axis activation, but also induces long-term psychophysiological changes in rodents, promoting depressive-like be...

Full description

Bibliographic Details
Main Authors: Jui-Hu Shih, 施睿琥
Other Authors: I-Hsun Li
Format: Others
Language:zh-TW
Published: 2016
Online Access:http://ndltd.ncl.edu.tw/handle/94650649733038475975
id ndltd-TW-104NDMC0659008
record_format oai_dc
spelling ndltd-TW-104NDMC06590082017-09-03T04:24:53Z http://ndltd.ncl.edu.tw/handle/94650649733038475975 Exploring the Neuroprotective Effects of Resveratrol against MDMA-induced Neurotoxicity in Rats Using Positron Emission Tomography 利用正子造影於大鼠模式探討白藜蘆醇抗MDMA神經毒性之保護作用 Jui-Hu Shih 施睿琥 博士 國防醫學院 醫學科學研究所 104 3,4-methylenedioxymethamphetamine (MDMA) is a widely misused drug that has been reported to evoke acute weight loss and hypothalamic-pituitary-adrenal axis activation, but also induces long-term psychophysiological changes in rodents, promoting depressive-like behavior and reducing the density of brain serotonin transporters (SERT). Resveratrol (RSV) is a natural polyphenolic phytoalexin and known for its antioxidant, antidepressant, and neuroprotective effects. However, biological targets of RSV as well as its neuroprotective effects against MDMA are still poorly understood. In this study, we examined binding potency of RSV and MDMA to SERT using small-animal positron emission tomography (PET) with the SERT radioligand, N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) and investigated the protection of RSV against the acute and long-term adverse effects of MDMA. RSV was found to exhibit binding potentials to SERT in vivo in a dose-dependent manner with variation among brain regions. To assess the protection by RSV against the acute and long-term adverse effects of MDMA, we injected animals with RSV (20 mg/kg, i.p.) and MDMA (10 mg/kg, s.c.) twice daily for 4 consecutive days. Small-animal PET imaging data showed that RSV protected against the MDMA-induced decrease in SERT availability in the midbrain and the thalamus 2 weeks following the co-treatment. RSV also prevented the MDMA-evoked increase in immobility in the forced swim test. Remarkably, RSV inhibited the MDMA-induced elevation in plasma corticosterone. Together, these findings suggest that RSV is not only a potential antidepressant, but that it also confers protection against the neurobiological and behavioral effects of MDMA. I-Hsun Li 李宜勳 2016 學位論文 ; thesis 76 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 博士 === 國防醫學院 === 醫學科學研究所 === 104 === 3,4-methylenedioxymethamphetamine (MDMA) is a widely misused drug that has been reported to evoke acute weight loss and hypothalamic-pituitary-adrenal axis activation, but also induces long-term psychophysiological changes in rodents, promoting depressive-like behavior and reducing the density of brain serotonin transporters (SERT). Resveratrol (RSV) is a natural polyphenolic phytoalexin and known for its antioxidant, antidepressant, and neuroprotective effects. However, biological targets of RSV as well as its neuroprotective effects against MDMA are still poorly understood. In this study, we examined binding potency of RSV and MDMA to SERT using small-animal positron emission tomography (PET) with the SERT radioligand, N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) and investigated the protection of RSV against the acute and long-term adverse effects of MDMA. RSV was found to exhibit binding potentials to SERT in vivo in a dose-dependent manner with variation among brain regions. To assess the protection by RSV against the acute and long-term adverse effects of MDMA, we injected animals with RSV (20 mg/kg, i.p.) and MDMA (10 mg/kg, s.c.) twice daily for 4 consecutive days. Small-animal PET imaging data showed that RSV protected against the MDMA-induced decrease in SERT availability in the midbrain and the thalamus 2 weeks following the co-treatment. RSV also prevented the MDMA-evoked increase in immobility in the forced swim test. Remarkably, RSV inhibited the MDMA-induced elevation in plasma corticosterone. Together, these findings suggest that RSV is not only a potential antidepressant, but that it also confers protection against the neurobiological and behavioral effects of MDMA.
author2 I-Hsun Li
author_facet I-Hsun Li
Jui-Hu Shih
施睿琥
author Jui-Hu Shih
施睿琥
spellingShingle Jui-Hu Shih
施睿琥
Exploring the Neuroprotective Effects of Resveratrol against MDMA-induced Neurotoxicity in Rats Using Positron Emission Tomography
author_sort Jui-Hu Shih
title Exploring the Neuroprotective Effects of Resveratrol against MDMA-induced Neurotoxicity in Rats Using Positron Emission Tomography
title_short Exploring the Neuroprotective Effects of Resveratrol against MDMA-induced Neurotoxicity in Rats Using Positron Emission Tomography
title_full Exploring the Neuroprotective Effects of Resveratrol against MDMA-induced Neurotoxicity in Rats Using Positron Emission Tomography
title_fullStr Exploring the Neuroprotective Effects of Resveratrol against MDMA-induced Neurotoxicity in Rats Using Positron Emission Tomography
title_full_unstemmed Exploring the Neuroprotective Effects of Resveratrol against MDMA-induced Neurotoxicity in Rats Using Positron Emission Tomography
title_sort exploring the neuroprotective effects of resveratrol against mdma-induced neurotoxicity in rats using positron emission tomography
publishDate 2016
url http://ndltd.ncl.edu.tw/handle/94650649733038475975
work_keys_str_mv AT juihushih exploringtheneuroprotectiveeffectsofresveratrolagainstmdmainducedneurotoxicityinratsusingpositronemissiontomography
AT shīruìhǔ exploringtheneuroprotectiveeffectsofresveratrolagainstmdmainducedneurotoxicityinratsusingpositronemissiontomography
AT juihushih lìyòngzhèngzizàoyǐngyúdàshǔmóshìtàntǎobáilílúchúnkàngmdmashénjīngdúxìngzhībǎohùzuòyòng
AT shīruìhǔ lìyòngzhèngzizàoyǐngyúdàshǔmóshìtàntǎobáilílúchúnkàngmdmashénjīngdúxìngzhībǎohùzuòyòng
_version_ 1718525740924796928